Novel bicyclic lactam inhibitors of thrombin:: Highly potent and selective inhibitors

被引:18
|
作者
St-Denis, Y
Lévesque, S
Bachand, B
Edmunds, JJ
Leblond, L
Préville, P
Tarazi, M
Winocour, PD
Siddiqui, MA
机构
[1] Shire BioChem, Laval, PQ H7V 4A7, Canada
[2] Pfizer Global Res & Dev, Ann Arbor, MI 48105 USA
关键词
D O I
10.1016/S0960-894X(02)00131-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The potency and selectivity of a previous series of low molecular weight thrombin inhibitors were improved through modifications of the P1 and P3 residues. Introduction of diphenyl substituted sulfonamides in the P3 moiety led to highly efficacious compounds. By correctly selecting the combination of P1 and P3 residues, high levels of potency, selectivity and in vivo efficacy were obtained. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1181 / 1184
页数:4
相关论文
共 50 条
  • [41] The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS)
    Cheshire, David R.
    Aberg, Anders
    Andersson, Gunilla M. K.
    Andrews, Glen
    Beaton, Haydn G.
    Birkinshaw, Timothy N.
    Boughton-Smith, Nigel
    Connolly, Stephen
    Cook, Tony R.
    Cooper, Anne
    Cooper, Sally L.
    Cox, David
    Dixon, John
    Gensmantel, Nigel
    Hamley, Peter J.
    Harrison, Richard
    Hartopp, Paul
    Kack, Helena
    Leeson, Paul D.
    Luker, Timothy
    Mete, Antonio
    Millichip, Ian
    Nicholls, David J.
    Pimm, Austen D.
    St-Gallay, Steve A.
    Wallace, Alan V.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) : 2468 - 2471
  • [42] Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B
    Van der Walt, Mietha M.
    Terre'Blanche, Gisella
    Petzer, Jacobus P.
    Petzer, Anel
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 1193 - 1199
  • [43] Novel thrombin inhibitors
    Lloyd, AW
    [J]. DRUG DISCOVERY TODAY, 1996, 1 (12) : 533 - 533
  • [44] Novel thrombin inhibitors
    不详
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (06) : 591 - 594
  • [45] β-arylaminoketones as potent thrombin inhibitors.
    Bai, X
    Gu, X
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U130 - U130
  • [46] SYNTHETIC SELECTIVE INHIBITORS OF THROMBIN
    OKAMOTO, S
    HIJIKATAOKUNOMIYA, A
    [J]. PROTEOLYTIC ENZYMES IN COAGULATION, FIBRINOLYSIS, AND COMPLEMENT ACTIVATION, PART A, 1993, 222 : 328 - 340
  • [47] PHARMACOLOGY OF SELECTIVE THROMBIN INHIBITORS
    MARKWARDT, F
    [J]. NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1988, 30 (03): : 161 - 165
  • [48] Highly potent protease inhibitors with novel escape pathways
    Afonina, E.
    Gulnik, S. V.
    Eissenstat, M.
    Yokoe, H.
    Yu, B.
    Parkin, N. T.
    Erickson, J. W.
    [J]. ANTIVIRAL THERAPY, 2007, 12 : S21 - S21
  • [49] Highly potent protease inhibitors with novel escape pathways
    Afonina, E.
    Gulnik, S. V.
    Eissenstat, M.
    Yokoe, H.
    Yu, B.
    Parkin, N. T.
    Erickson, J. W.
    [J]. ANTIVIRAL THERAPY, 2007, 12 (05) : S21 - S21
  • [50] Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors
    Ye, Xiaocong M.
    Konradi, Andrei W.
    Sun, Minghua
    Yuan, Shendong
    Aubele, Danielle L.
    Dappen, Michael
    Dressen, Darren
    Garofalo, Albert W.
    Jagodzinski, Jacek J.
    Latimer, Lee
    Probst, Gary D.
    Sham, Hing L.
    Wone, David
    Xu, Ying-zi
    Ness, Daniel
    Brigham, Elizabeth
    Kwong, Grace T.
    Willtis, Chris
    Tonn, George
    Goldbach, Erich
    Quinn, Kevin P.
    Zhang, Hongbin H.
    Sauer, John-Michael
    Bova, Michael
    Basi, Guriqbal S.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (04) : 996 - 1000